Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inhibrx Biosciences (INBX) Tax Provisions (2023 - 2025)

Inhibrx Biosciences (INBX) has disclosed Tax Provisions for 3 consecutive years, with $2000.0 as the latest value for Q2 2025.

  • Quarterly Tax Provisions changed 0.0% to $2000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $2000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $2000.0 for FY2025, 0.0% changed from the prior year.
  • Tax Provisions for Q2 2025 was $2000.0 at Inhibrx Biosciences, roughly flat from $2000.0 in the prior quarter.
  • The five-year high for Tax Provisions was $5000.0 in Q2 2023, with the low at -$4000.0 in Q4 2023.
  • Average Tax Provisions over 3 years is $1400.0, with a median of $2000.0 recorded in 2023.
  • The sharpest move saw Tax Provisions tumbled 60.0% in 2024, then changed 0.0% in 2025.
  • Over 3 years, Tax Provisions stood at -$4000.0 in 2023, then skyrocketed by 150.0% to $2000.0 in 2024, then changed by 0.0% to $2000.0 in 2025.
  • According to Business Quant data, Tax Provisions over the past three periods came in at $2000.0, $2000.0, and -$4000.0 for Q2 2025, Q2 2024, and Q4 2023 respectively.